IA
IOVA icon

IndexIQ Advisors’s Iovance Biotherapeutics IOVA Stock Holding History

IndexIQ Advisors’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-6,997
Closed -$325K – 1222
2020
Q4 		$325K Buy
6,997
+723
+12% +$28.7K 0.01% 618
2020
Q3 		$207K Buy
6,274
+340
+6% +$10.4K 0.01% 619
2020
Q2 		$163K Sell
5,934
-314
-5% -$10.3K 0.01% 764
2020
Q1 		$187K Buy
+6,248
New +$166K 0.01% 508

Other funds holding IOVA

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

IndexIQ Advisors's IOVA Position: Q1 2021 in Review

IndexIQ Advisors sold out of Iovance Biotherapeutics (IOVA) in Q1 2021, closing a stake of 6,997 shares — an estimated $325K sold.

IndexIQ Advisors first reported a position in IOVA in Q1 2020 and held it in 4 quarters. The position peaked at $325K in Q4 2020. 252 funds tracked by Wall St. Rank hold IOVA as of Q1 2021.

  • IndexIQ Advisors reported no remaining Iovance Biotherapeutics position as of Q1 2021 after selling out during the quarter.
  • IndexIQ Advisors sold 6,997 Iovance Biotherapeutics shares in Q1 2021, an estimated $325K.
  • IndexIQ Advisors first reported a position in Iovance Biotherapeutics in Q1 2020 and held it in 4 quarters.
  • IndexIQ Advisors's Iovance Biotherapeutics position peaked at $325K in Q4 2020.
  • 252 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q1 2021.

Based on IndexIQ Advisors's 13F filing for Q1 2021, filed 7 May 2021.